Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$34.4M |
| 2 |
LM
Legg Mason, Inc.
LM
|
+$15.7M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$12.8M |
| 4 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$12M |
| 5 |
GLIBA
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
|
+$8.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$44.5M |
| 2 |
CZR
Caesars Entertainment Corporation
CZR
|
+$28.2M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$27M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$21M |
| 5 |
IBKC
IBERIABANK Corp
IBKC
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 16.96% |
| 3 | Financials | 14.62% |
| 4 | Consumer Discretionary | 8.11% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
MSCI
MSCI
$41B
| – | – |
-10,769
| Closed | -$2.78M |
|
1227
M&T Bank
MTB
$34.7B
| – | – |
-27,046
| Closed | -$4.59M |
|
1228
Meritage Homes
MTH
$4.67B
| – | – |
-79,566
| Closed | -$2.43M |
|
1229
Matrix Service
MTRX
$311M
| – | – |
-22,810
| Closed | -$522K |
|
1230
Neurocrine Biosciences
NBIX
$15.5B
| – | – |
-28,537
| Closed | -$3.07M |
|
1231
Netflix
NFLX
$331B
| – | – |
-78,140
| Closed | -$2.53M |
|
1232
NiSource
NI
$19.5B
| – | – |
-7,316
| Closed | -$204K |
|
1233
New Jersey Resources
NJR
$5.43B
| – | – |
-8,880
| Closed | -$396K |
|
1234
NNN REIT
NNN
$8.8B
| – | – |
-198,721
| Closed | -$10.7M |
|
1235
NRG Energy
NRG
$23.8B
| – | – |
-5,081
| Closed | -$202K |
|
1236
Napco Security Technologies
NSSC
$1.36B
| – | – |
-19,554
| Closed | -$287K |
|
1237
NETSCOUT
NTCT
$2.8B
| – | – |
-38,091
| Closed | -$917K |
|
1238
Nutanix
NTNX
$18.3B
| – | – |
-38,324
| Closed | -$1.2M |
|
1239
Northern Trust
NTRS
$33.6B
| – | – |
-6,596
| Closed | -$701K |
|
1240
Nucor
NUE
$55.3B
| – | – |
-5,217
| Closed | -$294K |
|
1241
Northwest Bancshares
NWBI
$2.26B
| – | – |
-27,730
| Closed | -$461K |
|
|
ADAM
1242
Adamas Trust
ADAM
$893M
| – | – |
-4,096
| Closed | -$102K |
|
1243
Ollie's Bargain Outlet
OLLI
$4.6B
| – | – |
-25,914
| Closed | -$1.69M |
|
1244
Olin
OLN
$2.1B
| – | – |
-142,804
| Closed | -$2.46M |
|
1245
Option Care Health
OPCH
$3.55B
| – | – |
-16,721
| Closed | -$249K |
|
1246
Organogenesis Holdings
ORGO
$232M
| – | – |
-15,000
| Closed | -$72K |
|
1247
O'Reilly Automotive
ORLY
$72.1B
| – | – |
-146,850
| Closed | -$4.29M |
|
1248
PagSeguro Digital
PAGS
$2.38B
| – | – |
-24,745
| Closed | -$845K |
|
1249
Paycom
PAYC
$10.3B
| – | – |
-906
| Closed | -$240K |
|
1250
PG&E
PCG
$38.8B
| – | – |
-17,943
| Closed | -$195K |
|
Similar funds
Paul Tudor Jones's Q1 2020 Portfolio in Review
As of Q1 2020, Paul Tudor Jones held 1,500 positions worth $1.12B, down 50% from $2.23B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Paul Tudor Jones withdrew a net $741M in Q1 2020, closing 486 positions and reducing 367 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Paul Tudor Jones opened a new position in GCI Liberty, Inc. Class A Common Stock (DE) worth $7.42M.
- Paul Tudor Jones's largest Q1 2020 buy was GCI Liberty, Inc. Class A Common Stock (DE): 130,150 shares worth $7.42M.
- Paul Tudor Jones added most to RTX Corp in Q1 2020, an estimated $34.4M increase.
- Paul Tudor Jones's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $44.5M.
- Paul Tudor Jones fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $27M.
- Paul Tudor Jones's ten largest holdings make up 28% of its $1.12B portfolio in Q1 2020.
- Paul Tudor Jones opened 388 new positions and closed 486 in Q1 2020.
- Paul Tudor Jones's portfolio value fell 50% quarter-over-quarter to $1.12B.
Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.